The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles
Open accessAbstract
This review which is the second in this series summarises the most common synthetic routes as applied to the preparation of many modern pharmaceutical compounds categorised as containing a six-membered heterocyclic ring. The reported examples are based on the top retailing drug molecules combining synthetic information from both scientific journals and the wider patent literature. It is hoped that this compilation, in combination with the previously published review on five-membered rings, will form a comprehensive foundation and reference source for individuals interested in medicinal, synthetic and preparative chemistry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation
Ley, S. V., & Thomas, A. W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200300594 · Cited by 2,554
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
International Journal of ChemTech Research
(2020) · International Journal of ChemTech Research · doi:10.20902/ct · Cited by 1,532
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Vorbrüggen, H., Krolikiewicz, K., & Bennua, B. (1981) · Chemische Berichte · doi:10.1002/cber.19811140404 · Cited by 763
Summa, V., Petrocchi, A., Bonelli, F., Crescenzi, B., Donghi, M., Ferrara, M., Fiore, F., Gardelli, C., Gonzalez Paz, O., Hazuda, D. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800245z · Cited by 633
Journal of Chemical and Pharmaceutical Research
Deivasigamani, B. (2011) · Cited by 522
Muscarinic Receptor Agonists and Antagonists
Broadley, K. J., & Kelly, D. R. (2001) · Molecules · doi:10.3390/60300142 · Cited by 504
Groll, M., Berkers, C. R., Ploegh, H. L., & Ovaa, H. (2006) · Structure · doi:10.1016/j.str.2005.11.019 · Cited by 473
Review article: the clinical pharmacology of proton pump inhibitors
SACHS, G., SHIN, J. M., & HOWDEN, C. W. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02943.x · Cited by 407
Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery
Pryde, D. C., Dalvie, D., Hu, Q., Jones, P., Obach, R. S., & Tran, T.-D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100888d · Cited by 345
Böhm, H.-J., Flohr, A., & Stahl, M. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.10.009 · Cited by 335
Heteroaromatic Rings of the Future
Pitt, W. R., Parry, D. M., Perry, B. G., & Groom, C. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801513z · Cited by 332
Studies on Condensed Pyrimidine Systems. IX. The Synthesis of Some 6-Substituted Purines
Elion, G. B., Burgi, E., & Hitchings, G. H. (1952) · Journal of the American Chemical Society · doi:10.1021/ja01122a037 · Cited by 298
The Organic Chemistry of Drug Design and Drug Action
Cooper, M. E. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03199-x · Cited by 292
Mode of Action of Fluoroquinolones
Hooper, D. C. (1999) · Drugs · doi:10.2165/00003495-199958002-00002 · Cited by 290
Heterocyclic Chemistry: Volume I: Principles, Three- and Four-Membered Heterocycles
Gupta, R. R., Kumar, M., & Gupta, V. (1998) · Springer eBooks · doi:10.1007/978-3-642-72276-9 · Cited by 272
Cantello, B. C. C., Cawthorne, M. A., Cottam, G. P., Duff, P. T., Haigh, D., Hindley, R. M., Lister, C. A., Smith, S. A., & Thurlby, P. L. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00049a017 · Cited by 267
Molecules that changed the world
(2008) · Choice Reviews Online · doi:10.5860/choice.46-1488 · Cited by 261
Beenen, M. A., An, C., & Ellman, J. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800829y · Cited by 231
Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond
Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 197
A flow-based synthesis of Imatinib: the API of Gleevec
Hopkin, M. D., Baxendale, I. R., & Ley, S. V. (2010) · Chemical Communications · doi:10.1039/c001550d · Cited by 190
Self-citationWatanabe, M., Koike, H., Ishiba, T., Okada, T., Seo, S., & Hirai, K. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(96)00248-9 · Cited by 167
Guetzoyan, L. J., Nikbin, N., Baxendale, I. R., & Ley, S. V. (2012) · Chemical Science · doi:10.1039/c2sc21850j · Cited by 130
Self-citationThe mechanisms of heterocyclic ring closures
KATRITZKY, A. R., Ostercamp, D. L., & Yousaf, T. I. (1987) · Tetrahedron · doi:10.1016/s0040-4020(01)87693-6 · Cited by 125
The synthesis of BRL 49653 - a novel and potent antihyperglycaemic agent
Cantello, B. C. C., Cawthorne, M. A., Haigh, D., Hindley, R. M., Smith, S. A., & Thurlby, P. L. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80325-5 · Cited by 112
Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection
Pirrone, V., Thakkar, N. J., Jacobson, J. M., Wigdahl, B. L., & Krebs, F. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00976-10 · Cited by 105
Pharmacophore-Based discovery of substituted pyridines as novel dopamine transporter inhibitors
Enyedy, I. J., Sakamuri, S., Zaman, W. A., Johnson, K. M., & Wang, S. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00943-5 · Cited by 88
Darkes, M. J. M., Plosker, G. L., & Jarvis, B. (2002) · American Journal of Cancer · doi:10.2165/00024669-200201010-00006 · Cited by 78
Science, art and drug discovery: a personal perspective
Campbell, S. F. (2000) · Clinical Science · doi:10.1042/cs0990255 · Cited by 75
11 Years of Cyanopyrrolidines as DPP-IV Inhibitors
Peters, J. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780091000 · Cited by 71
Mattei, P., Boehringer, M., Giorgio, P. D., Fischer, H., Hennig, M., Huwyler, J., Koçer, B., Kuhn, B., Loeffler, B. M., MacDonald, A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.024 · Cited by 69
Deadman, B. J., Hopkin, M. D., Baxendale, I. R., & Ley, S. V. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob27003j · Cited by 65
Self-citationGohlke, H., Gündisch, D., Schwarz, S., SEITZ, G., Tilotta, M. C., & Wegge, T. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010936y · Cited by 60
Microwave-assisted synthesis of the antihyperglycemic drug rosiglitazone
Gaonkar, S. L., & Shimizu, H. (2010) · Tetrahedron · doi:10.1016/j.tet.2010.03.006 · Cited by 56
Kumar, B. R. P., Nanjan, M. J., Suresh, B., et al. (2006) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570430413 · Cited by 53
Pharmaceutical Strategy and Innovation: An Academics Perspective
Baxendale, I. R., Hayward, J. J., Ley, S. V., & Tranmer, G. K. (2007) · ChemMedChem · doi:10.1002/cmdc.200700008 · Cited by 49
Self-citationPrzyklenk, K., & Kloner, R. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03592.x · Cited by 48
The Kondrat’eva Reaction in Flow: Direct Access to Annulated Pyridines
Lehmann, J., Alzieu, T., Martin, R. E., & Britton, R. (2013) · Organic Letters · doi:10.1021/ol4013525 · Cited by 45
Roy, B. N., Singh, G. P., Srivastava, D., Jadhav, H. S., Saini, M. B., & Aher, U. P. (2009) · Organic Process Research & Development · doi:10.1021/op800228h · Cited by 37
Powell, D. W., Gopalsamy, A., Wang, Y. D., Zhang, N., Miranda, M., McGinnis, J. P., & Rabindran, S. K. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.116 · Cited by 36
Preparation of 1,5-Methano-2,3,4,5- tetrahydro-1H-3-benzazepine via Pd-Catalyzed Cyclization
Singer, R. A., McKinley, J. D., Barbe, G., & Farlow, R. A. (2004) · Organic Letters · doi:10.1021/ol049316s · Cited by 28
Pye, P. J., Zhong, Y., Jones, G. O., Reamer, R. A., Houk, K. N., & Askin, D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703681 · Cited by 26
Olesen, P. H., Tønder, J. E., Hansen, J. B., et al. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00063-8 · Cited by 18
Cited by
Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501100b · Cited by 6,418
Prescribed drugs containing nitrogen heterocycles: an overview
Heravi, M. M., & Zadsirjan, V. (2020) · RSC Advances · doi:10.1039/d0ra09198g · Cited by 1,194
Modern advances in heterocyclic chemistry in drug discovery
Taylor, A. P., Robinson, R. P., Fobian, Y. M., Blakemore, D. C., Jones, L. H., & Fadeyi, O. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00936k · Cited by 887
Medicinal attributes of 1,2,3-triazoles: Current developments
Dheer, D., Singh, V., & Shankar, R. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.01.010 · Cited by 873
Metal-organic framework (MOF)-derived catalysts for fine chemical production
Konnerth, H., Matsagar, B. M., Chen, S. S., Prechtl, M. H. G., Shieh, F.-K., & Wu, K. C.-W. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213319 · Cited by 627
Metadata
- Authors
- Baumann, M., & Baxendale, I. R.
- Venue
- Beilstein Journal of Organic Chemistry
- Publisher
- Beilstein Institut
- Published
- 2013-10-30
- Volume
- 9
- Pages
- 2265-2319
- ISSN
- 1860-5397 (ISSN-L)
- OpenAlex
- W2111537995
- Cited by
- 841
- References
- 46
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.